熱門資訊> 正文
Lexicon Pharmaceuticals宣布总裁兼首席运营官Jeff Wade离职
2024-09-16 20:41
- Lexicon Pharmaceuticals (NASDAQ:LXRX) on Monday said its president and COO, Jeff Wade, is departing the company on or about September 30.
- The company said that a search for a new COO is underway.
- Wade spent 25 years in finance, development, legal, and leadership roles at Lexicon.
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals Needs To See Real Revenue Acceleration And Clinical/Regulatory Success
- Lexicon to face FDA AdCom over diabetes therapy review
- Lexicon to cut 50% of workforce to focus on sotagliflozin
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。